Search

Author/Creator Ku, B. J.

1. Efficacy and safety of teneligliptin, a dipeptidyl peptidase‐4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16‐week, randomized, double‐blind, placebo‐controlled phase III trial. Issue 3 (18th January 2015)

Authors:
Kim, M. K.; Rhee, E.‐J.; Han, K. A.; Woo, A. C.; Lee, M.‐K.; Ku, B. J.; Chung, C. H.; Kim, K.‐A.; Lee, H. W.; Park, I. B.; Park, J. Y.; Chul Jang, H. C.; Park, K. S.; Jang, W. I.; Cha, B. Y.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 17:Issue 3(2015:Mar.)
Page Start:
309
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of teneligliptin, a novel dipeptidyl peptidase‐4 inhibitor, in Korean patients with type 2 diabetes mellitus: a 24‐week multicentre, randomized, double‐blind, placebo‐controlled phase III trial. Issue 5 (18th March 2016)

Authors:
Hong, S.; Park, C.‐Y.; Han, K. A.; Chung, C. H.; Ku, B. J.; Jang, H. C.; Ahn, C. W.; Lee, M.‐K.; Moon, M. K.; Son, H. S.; Lee, C. B.; Cho, Y.‐W.; Park, S.‐W.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 18:Issue 5(2016)
Page Start:
528
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension. Issue 6 (8th February 2015)

Authors:
Jin, S.‐M.; Park, C.‐Y.; Cho, Y. M.; Ku, B. J.; Ahn, C. W.; Cha, B.‐S.; Min, K. W.; Sung, Y. A.; Baik, S. H.; Lee, K. W.; Yoon, K.‐H.; Lee, M.‐K.; Park, S. W.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 17:Issue 6(2015:Jun.)
Page Start:
599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension. Issue 6 (8th February 2015)

Authors:
Jin, S.‐M.; Park, C.‐Y.; Cho, Y. M.; Ku, B. J.; Ahn, C. W.; Cha, B.‐S.; Min, K. W.; Sung, Y. A.; Baik, S. H.; Lee, K. W.; Yoon, K.‐H.; Lee, M.‐K.; Park, S. W.
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 17:Issue 6(2015:Jun.)
Page Start:
599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗